Cardinal Health (CAH) Set to Announce Quarterly Earnings on Friday

Cardinal Health (NYSE:CAH) will be issuing its quarterly earnings data before the market opens on Friday, November 1st. Analysts expect the company to announce earnings of $1.64 per share for the quarter. Cardinal Health has set its FY 2025 guidance at 7.550-7.700 EPS and its FY25 guidance at $7.55-7.70 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 EPS for the quarter, topping the consensus estimate of $1.74 by $0.10. The firm had revenue of $59.87 billion during the quarter, compared to analysts’ expectations of $58.74 billion. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The firm’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.55 earnings per share. On average, analysts expect Cardinal Health to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cardinal Health Stock Performance

Shares of CAH stock opened at $107.89 on Thursday. Cardinal Health has a fifty-two week low of $90.19 and a fifty-two week high of $116.05. The stock’s fifty day moving average is $111.65 and its two-hundred day moving average is $104.10. The firm has a market capitalization of $26.28 billion, a P/E ratio of 47.95, a PEG ratio of 1.57 and a beta of 0.60.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were paid a $0.506 dividend. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.02 annualized dividend and a dividend yield of 1.88%. The ex-dividend date was Tuesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 89.78%.

Wall Street Analyst Weigh In

A number of research firms have commented on CAH. JPMorgan Chase & Co. increased their price objective on shares of Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. UBS Group increased their price target on Cardinal Health from $125.00 to $134.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. Robert W. Baird boosted their price objective on Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. Deutsche Bank Aktiengesellschaft raised their target price on Cardinal Health from $115.00 to $119.00 and gave the stock a “hold” rating in a research note on Friday, August 16th. Finally, Evercore ISI lifted their price target on Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus target price of $120.18.

Insider Activity

In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the sale, the insider now directly owns 94,529 shares in the company, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, CFO Aaron E. Alt sold 2,323 shares of Cardinal Health stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $108.91, for a total value of $252,997.93. Following the completion of the transaction, the chief financial officer now owns 36,867 shares in the company, valued at $4,015,184.97. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 113,963 shares of company stock valued at $12,379,980. 0.15% of the stock is currently owned by company insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.